Skip to main content

Table 3 Reduced access to diabetes medicine

From: Self-isolation negatively impacts self-management of diabetes during the coronavirus (COVID-19) pandemic

A

  

Outcome variable (Reduced access to diabetes medicine) response category

P-value

Exposure variable

Exposure variable category

Yes

No/not sure

Age group

 < 50 years

35 (17.2%)

168 (82.8%)

0.99

50 years or above

59 (17.4%)

281 (82.6%)

Gender

Male

48 (16.8%)

237 (83.2%)

0.82

Female

46 (17.8%)

212 (82.2%)

Duration of diabetes

Up to 5 years

36 (17.0%)

176 (83.0%)

0.91

 > 5 years

58 (17.5%)

273 (82.5%)

Treatment of diabetes

Non-insulin

48 (13.4%)

310 (86.6%)

0.001*

Insulin/combined

46 (25.0%)

138 (75.0%)

Presence of diabetes complications like retinopathy

Yes

14 (26.9%)

38 (73.1%)

0.08

No/not sure

79 (16.2%)

409 (83.8%)

Needing to self-isolate

Yes

28 (25.5%)

82 (74.5%)

0.02*

No/prefer not say

66 (15.2%)

367 (84.8%)

Duration of self-isolation

Up to 1 week

8 (21.1%)

30 (78.9%)

0.64

More than 1 week

19 (26.0%)

54 (74.0%)

B

    

Exposure variable

Exposure variable category

Association with reduced access to diabetes medicine

P-value

Odds Ratio (95% CI)

Treatment of diabetes

Insulin or combined

2.13

(1.35–3.35)

0.001*

Non-insulin (Reference)

Needing to self-isolate

Yes

1.86

(1.11–3.09)

0.02*

No/prefer not say (Reference)

  1. A Chi-square results showing association of various exposure variables with the outcome variable of reduced access to diabetes medicine during the pandemic compared to pre-pandemic. *represent significant p-values. B Adjusted Multivariate Logistic Regression results showing needing to self-isolate and being on insulin treatment are associated significantly with reduced access to diabetes medicine during the pandemic compared to pre-pandemic